Navigation Links
Marijuana

ProductsMarijuana
Company ARUP Laboratories
Item Marijuana
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Marijuana - Rapid Test
2. Drugs of Abuse Confirmation/Quantitation-Cannabinoids (Marijuana)-Meconium
3. Marijuana Metabolite (9-carboxy-THC) Confirmation/Quantitation, Urine
4. Marijuana Confirmation/Quantitation, Meconium
5. Meconium, Marijuana Confirmation/Quantitation
TAG: Marijuana
...any special order products are offered as 1-piece ...modular instruments may be customized with handles...ulation and flush ports. Many standard patterns ar...ations may affect delivery times. , Please Note: ...
...any special order products are offered as 1-piece ...modular instruments may be customized with handles...ulation and flush ports. Many standard patterns ar...ations may affect delivery times. , Please Note: ...
...any special order products are offered as 1-piece ...modular instruments may be customized with handles...ulation and flush ports. Many standard patterns ar...ations may affect delivery times. , Please Note: ...
The Featured Products are kept in stock at Mediflex and are offered as 1-piece or modular in regular or extra long lengths. All come equipped with insulation, flush ports, rotating shafts, ratchets (
Medicine Products:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...clinical study carried out by Professor Ian Reed a... Zealand has found that the drug Zometa manufactur... than the drug Actonel produced by Procter and Gam...n which the bones breaks or becomes weak faster th...
...that using antiplatelet medication called clopidog...ces the risk of death from cardiovascular problems...per was published in the latest issue of JAMA. Dua...taneous coronary intervention using a combination ...
...in life are just taken for granted. But it turns o...lanations to such things are projected. One such e...ale and female voice.// An analysis of the brain s...evaluation of male and female voices found startli...
...ernment is supporting a programme named the "golde...together to validate medicine protocols //for the ...and Industrial Research, the Indian Council of Med...dian System of Medicines. Health Minister Anbumani...
Other Medicine News:Health News:Medicines Used In Antiplatelet Therapy Can Reduce Heart Attacks And Strokes 2Health News:Have You Ever Wondered Why Male And Female Voices Differ? 2
(Date:8/14/2008)... Aug. 14 /- Pharmasset, Inc...l company committed to,discovering, developing and...ions, reported unaudited financial results for the...set reported a net loss attributable to,common sto... $0.69 for the,quarter ended June 30, 2008, as com...
(Date:8/14/2008)...) Technology Evaluated to Enable Targeting and Inc...equencing, LEXINGTON, Mass. and HEIDELBERG, Germa...ional Genomics Research Institute (TGen) today ann...Gen will evaluate,Next-Generation-Sequencing equip...m(R) Microarray Technology., febit,s HybSelect(TM...
(Date:8/13/2008)... /- As biotechnology,pharm...y move clinical,trials beyond their own borders to...urope and South America, complicated regulatory en...siness, according to an analysis by,Aon Corporatio...ap provides,those companies a visual representatio...
(Date:8/13/2008)...no(TM) - proves the ability to automatically measu...g samples, SANTA CLARA, Calif., Aug. 13 /PRNewswi...ard: NWCI) a cardiac diagnostic and services compa...al validation study of QTinno(TM),(the "NCE3 Study...eading,cardiac safety expert with extensive experi...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Researchers Create Protective Sac for Growing Stem Cells 15336 1Researchers Create Protective Sac for Growing Stem Cells 15336 2Kinetic Technologies Makers of Conquer 28R 29 Introduces New Website 15334 1ProActive Remedies LLC Announces Launch of New Allergy Medication 15332 1ProActive Remedies LLC Announces Launch of New Allergy Medication 15332 2Highmark Prominent Part of Pittsburgh City Skyline to Go Dark for One Hour to Support the Environment 15330 1Highmark Prominent Part of Pittsburgh City Skyline to Go Dark for One Hour to Support the Environment 15330 2
..., 2007 /PRNewswire-FirstCall/ -- Shire plc,announc...system),the first and only non-oral medication ap...ivity Disorder (ADHD) in children aged 6,to 12 yea...ntrol,and tolerability, according to results of a ...n Psychiatric Association (APA),annual meeting in ...
...hol Abuse Among ADHD Patients Nearly Triple That,o...llion People, INDIANAPOLIS, May 23, 2007 /PRNewswi... showed Strattera(R) (atomoxetine HCl),improved sy...r,(ADHD) in patients with comorbid alcohol abuse d... effectively with Strattera in,patients with both ...
Other Medicine Technology:12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 212-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 312-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 412-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 512-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 612-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 712-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 812-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 9Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6